Glucose Monitoring + Social Support for Gestational Diabetes

(GEMS-P Trial)

This trial tests whether a continuous glucose monitor, which displays blood sugar levels in real time on a smartphone app, combined with a group chat for mobile-based social support, can maintain healthy blood sugar levels during pregnancy. Pregnant participants in one group will use both the monitor and the chat, while another group will use only the monitor. The trial aims to determine if these tools improve blood sugar management. It is suitable for pregnant individuals who have had gestational diabetes, have a family member with type II diabetes, or have a BMI over 25, and are planning to deliver at Tufts Medicine in Boston. As an unphased trial, this study provides a unique opportunity to explore innovative tools for managing blood sugar during pregnancy.

The trial does not specify if you need to stop taking your current medications. However, if you have chronic illnesses that require regular medication, you may not be eligible to participate.

Research has shown that using a mobile app for support and remote monitoring safely manages gestational diabetes. Studies have found that these apps effectively help individuals control their blood sugar levels. Many participants reported positive experiences and found the digital support useful.

For real-time continuous glucose monitoring (CGM), research indicates it is generally safe and well-tolerated during pregnancy. Studies show that CGM provides instant blood sugar information, aiding in better management of gestational diabetes. Participants using CGM maintained more stable blood sugar levels and experienced few, if any, serious side effects.

Researchers are excited about this trial because it combines real-time continuous glucose monitoring with mobile-based social support, offering a novel approach to managing gestational diabetes. Unlike traditional methods that mainly involve dietary changes and insulin therapy, this trial's approach uses technology to provide immediate feedback on glucose levels and emotional support through a group chat. This could lead to better glucose management and improved outcomes for mothers by fostering a community that encourages adherence to healthy behaviors.

Research has shown that using a mobile health app with social support can help people with gestational diabetes manage their blood sugar more effectively. One study found that these tools encourage self-care, making it easier to handle the condition. Another review found that mobile health tools improved blood sugar control in pregnant individuals. In this trial, participants in Group 1 will use a mobile-based group chat for social support alongside real-time continuous glucose monitoring.